Sign Up to like & get
recommendations!
1
Published in 2020 at "Frontiers in Endocrinology"
DOI: 10.3389/fendo.2020.630875
Abstract: The discovery that sclerostin is the defective protein underlying the rare heritable bone mass disorder, sclerosteosis, ultimately led to development of anti-sclerostin antibodies as a new treatment for osteoporosis. In the era of large scale…
read more here.
Keywords:
research;
functional genomics;
genetic signals;
genomics research ... See more keywords